KUALA LUMPUR: German-based medical technology company, B. Braun will expand its portfolio of testing capabilities for healthcare solutions related to intravenous access, surgical technologies, intravenous systems, central venous puncture and pain control in Penang.
In a joint statement, the Malaysian Investment Development Authority (MIDA) and B. Braun said the volume of product testing has been tripled to more than 600,000 scientific measurements per annum due to the proven competencies, strong product knowledge and efficiency displayed by the local team of Malaysian engineers.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
